Vaccine · BLA
Kinrix NDC 58160-812
Corynebacterium diphtheriae toxoid antigen (Formaldehyde inactivated) 25 [iU]/.5mL + 7 more ingredients · Injection, Suspension · Intramuscular · GlaxoSmithKline Biologicals SA
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 58160-812-52 | 5816008125258160081252 | 10 SYRINGE in 1 CARTON (58160-812-52) / .5 mL in 1 SYRINGE (58160-812-43)Marketed from Jul 9, 2008 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Kinrix
- Generic name (nonproprietary)
- diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine
- Active ingredients
- Corynebacterium diphtheriae toxoid antigen (Formaldehyde inactivated) — 25 [iU]/.5mLClostridium tetani toxoid antigen (Formaldehyde inactivated) — 10 [iU]/.5mLBordetella pertussis filamentous hemagglutinin antigen (Formaldehyde inactivated) — 25 [iU]/.5mLBordetella pertussis pertactin antigen (Formaldehyde inactivated) — 8 ug/.5mLBordetella pertussis toxoid antigen (Formaldehyde, Glutaraldehyde inactivated) — 25 ug/.5mLPoliovirus type 1 antigen (Formaldehyde inactivated) — 40 [iU]/.5mLPoliovirus type 2 antigen (Formaldehyde inactivated) — 8 [iU]/.5mLPoliovirus type 3 antigen (Formaldehyde inactivated) — 32 [iU]/.5mL
- Dosage form
- Injection, Suspension
- Route
- Intramuscular
- Labeler
- GlaxoSmithKline Biologicals SANDC labeler code 58160
- Product type
- Vaccine
- Marketing category
- BLA — Biologics License ApplicationApplication BLA 125260
- Marketing start
- Listing expires
- Other FDA classes
- Actively Acquired Immunity (Physiologic effect)Actively Acquired Immunity (Physiologic effect)Actively Acquired Immunity (Physiologic effect)Actively Acquired Immunity (Physiologic effect)Actively Acquired Immunity (Physiologic effect)Actively Acquired Immunity (Physiologic effect)Actively Acquired Immunity (Physiologic effect)Actively Acquired Immunity (Physiologic effect)Diphtheria Toxoid (Chemical structure)Pertussis Vaccine (Chemical structure)Pertussis Vaccine (Chemical structure)Pertussis Vaccine (Chemical structure)Poliovirus Vaccines (Chemical structure)Poliovirus Vaccines (Chemical structure)Poliovirus Vaccines (Chemical structure)Tetanus Toxoid (Chemical structure)Inactivated (Chemical structure)Inactivated (Chemical structure)Inactivated (Chemical structure)Inactivated (Chemical structure)Inactivated (Chemical structure)Inactivated (Chemical structure)Inactivated (Chemical structure)Inactivated (Chemical structure)
- Identifiers
- Product ID 58160-812_0066d4bd-89fc-4bf7-80ce-4d9c49f59244SPL ID 0066d4bd-89fc-4bf7-80ce-4d9c49f59244
- Pharmacologic class
- Inactivated Bordetella Pertussis Vaccine; Inactivated Clostridium Tetani Vaccine; Inactivated Corynebacterium Diphtheriae Vaccine; Inactivated Poliovirus Vaccine
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Immunization administration (CPT 90460–90474)
Giving a vaccine is reported separately from the vaccine product code, with an immunization administration code. Which code applies depends on the patient's age, the route and whether counselling was provided.
- NDC on a medical claim
N458160081252followed by a unit qualifier and the quantityPackage 58160-0812-52. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
The FDA listing for this product does not reference a label (SPL) set.
About NDC 58160-812
- What is NDC 58160-812?
- 58160-812 is the product NDC for Kinrix, Corynebacterium diphtheriae toxoid antigen (Formaldehyde inactivated) 25 [iU]/.5mL + 7 more ingredients injection, suspension, listed with the FDA by GlaxoSmithKline Biologicals SA. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Kinrix (Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine).
- What is the active ingredient?
- Corynebacterium diphtheriae toxoid antigen (Formaldehyde inactivated), Clostridium tetani toxoid antigen (Formaldehyde inactivated), Bordetella pertussis filamentous hemagglutinin antigen (Formaldehyde inactivated), Bordetella pertussis pertactin antigen (Formaldehyde inactivated), Bordetella pertussis toxoid antigen (Formaldehyde, Glutaraldehyde inactivated), Poliovirus type 1 antigen (Formaldehyde inactivated), Poliovirus type 2 antigen (Formaldehyde inactivated), Poliovirus type 3 antigen (Formaldehyde inactivated).
- Who is the labeler?
- GlaxoSmithKline Biologicals SA, NDC labeler code 58160. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Kinrix?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.